GlobalData on MSN2d
FTC sues to block GTCR’s ‘unlawful acquisition’ of SurmodicsGTCR already owns the second largest medical device coatings manufacturer, Biocoat, and the FTC holds market monopoly ...
Axios on MSN2d
FTC sues to block medical device coatings dealThe Federal Trade Commission under President Trump is making its first move to challenge private equity in health care, by ...
The regulator says the proposed merger would give the combined company more than 50% of the market for a type of medical ...
The Federal Trade Commission has filed a lawsuit to block private equity firm GTCR BC Holdings from acquiring Surmodics, a medical technology company, arguing the deal would reduce competition for ...
Surmodics, Inc. (Nasdaq: SRDX), a provider of medical device and in vitro diagnostic technologies to the healthcare industry, ...
The Federal Trade Commission on March 6 sued to block GTCR’ s acquisition of Surmodics, alleging that “the deal, which seeks to combine the two largest manufacturers of critical medical device ...
Surmodics (NASDAQ:SRDX) fell 4.6% after the Federal Trade Commission filed a lawsuit to block its planned $627 million sale ...
The Rolling Meadows-based insurance broker is pushing back its forecast for when the transaction might close as the ...
The FTC said merging Surmodics with Biocoat, where GTCR has a majority stake, would result in one company with more than 50% ...
WASHINGTON (Reuters) - The U.S. Federal Trade Commission sued on Thursday to block medical device coatings maker Surmodics' ...
The U.S. Federal Trade Commission (FTC) has sued to block the planned acquisition of medical device company Surmodics (Nasdaq ...
The agency is challenging the deal, citing antitrust concerns due to GTCR's existing ownership of Surmodics' rival Biocoat.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback